Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for
Bernard A Fang1, Žaklina Kovačević1, Kyung Chan Park1
1Molecular Pharmacology and Pathology Program, Discipline of Pathology and Bosch Institute, Blackburn Building (D06), The University of Sydney, Sydney, NSW 2006, Australia.
Abstract:
N-myc down-regulated gene 1 (NDRG1) is a known metastasis suppressor in multiple cancers, being also involved in embryogenesis and development, cell growth and differentiation, lipid biosynthesis and myelination, stress responses and immunity. In addition to its primary role as a metastasis suppressor, NDRG1 can also influence other stages of carcinogenesis, namely angiogenesis and primary tumour growth. NDRG1 is regulated by multiple effectors in normal and neoplastic cells, including N-myc, histone acetylation, hypoxia, cellular iron levels and intracellular calcium. Further, studies have found that NDRG1 is up-regulated in neoplastic cells after treatment with novel iron chelators, which are a promising therapy for effective cancer management. Although the pathways by which NDRG1 exerts its functions in cancers have been documented, the relationship between the molecular structure of this protein and its functions remains unclear. In fact, recent studies suggest that, in certain cancers, NDRG1 is post-translationally modified, possibly by the activity of endogenous trypsins, leading to a subsequent alteration in its metastasis suppressor activity. This review describes the role of this important metastasis suppressor and discusses interesting unresolved issues regarding this protein.
Insights
N-myc down-regulated gene 1 (NDRG1) is a crucial metastasis suppressor in cancer. Its molecular structure and post-translational modifications, potentially by trypsins, impact its function, requiring further investigation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- N-myc down-regulated gene 1 (NDRG1) functions as a metastasis suppressor across various cancers.
- NDRG1 is implicated in embryogenesis, cell growth, differentiation, lipid metabolism, myelination, stress responses, and immunity.
- Its roles extend to angiogenesis and primary tumor growth, influencing carcinogenesis.
- NDRG1 regulation involves N-myc, histone acetylation, hypoxia, iron levels, and intracellular calcium.
- Iron chelators up-regulate NDRG1 in neoplastic cells, showing therapeutic potential.
Purpose of the Study:
- To review the multifaceted roles of NDRG1 in cancer.
- To discuss the unresolved relationship between NDRG1's molecular structure and its functions.
- To explore potential post-translational modifications affecting NDRG1 activity.
Main Methods:
- Literature review of existing studies on NDRG1.
- Analysis of molecular mechanisms regulating NDRG1.
- Discussion of recent findings on NDRG1 post-translational modifications.
Main Results:
- NDRG1 is a key metastasis suppressor with diverse cellular functions.
- NDRG1 activity is modulated by various cellular factors and treatments like iron chelators.
- Recent evidence suggests post-translational modifications, possibly by trypsins, alter NDRG1's metastasis suppressor activity.
Conclusions:
- NDRG1 is a vital protein in cancer progression and suppression.
- Understanding the structural basis and modifications of NDRG1 is critical for cancer therapy.
- Further research is needed to elucidate the precise mechanisms of NDRG1 function and regulation.
Related Concept Videos
Mitogens and the Cell Cycle
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Non-Canonical Wnt Signaling Pathways
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

